| 摘要 |
<p>Novel compositions and methods for treating myocardial and peripheral ischemia are disclosed which employ monocytes to provide localized, controlled doses of secreted therapeutic proteins to selected tissue areas. These proteins can be naturally produced by monocytes, or produced following genetic tranduction of monocytes or their progenitor cells with appropriate expression vectors.</p> |
